Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. financial statements

Dermata Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 7.56M10-K
Cash and equivalentsUSD 7.52M10-Q

Dermata Therapeutics, Inc. financials on 6ix · Dermata Therapeutics, Inc. on 6ix